Difficulty: Medium
Average Score: 77%
Practice
A nurse treating chronic asthmatic patients with methylxanthines must remember to increase the dosage when prescribing this medication simultaneously with
Correct answer
B
Rationale
In the context of hematology and pharmacology, understanding drug interactions is crucial for safe and effective patient care. In this scenario, the correct answer is option B) Phenobarbital, phenytoin, and rifampin.
Methylxanthines, like theophylline, are metabolized in the liver by the cytochrome P450 system. Phenobarbital, phenytoin, and rifampin are known to induce cytochrome P450 enzymes, leading to increased metabolism of methylxanthines. This accelerated metabolism can result in subtherapeutic levels of methylxanthines, reducing their effectiveness in treating chronic asthma.
Option A) Cimetidine, ciprofloxacin, and other fluoroquinolone antibiotics are inhibitors of cytochrome P450 enzymes, which would lead to increased levels of methylxanthines, potentially causing toxicity rather than the desired therapeutic effect.
Option C) Albuterol and TCAs do not significantly impact the metabolism of methylxanthines and do not require a dosage adjustment when used concurrently.
Option D) None of the listed drugs pose a risk when taken with methylxanthines is incorrect because, as explained above, certain drugs can interact with methylxanthines, affecting their metabolism and efficacy.
Educationally, this question highlights the importance of understanding drug interactions, especially in patients with chronic conditions like asthma who may be on multiple medications. Nurses need to be aware of potential interactions to ensure safe and effective pharmacological management for their patients.
Methylxanthines, like theophylline, are metabolized in the liver by the cytochrome P450 system. Phenobarbital, phenytoin, and rifampin are known to induce cytochrome P450 enzymes, leading to increased metabolism of methylxanthines. This accelerated metabolism can result in subtherapeutic levels of methylxanthines, reducing their effectiveness in treating chronic asthma.
Option A) Cimetidine, ciprofloxacin, and other fluoroquinolone antibiotics are inhibitors of cytochrome P450 enzymes, which would lead to increased levels of methylxanthines, potentially causing toxicity rather than the desired therapeutic effect.
Option C) Albuterol and TCAs do not significantly impact the metabolism of methylxanthines and do not require a dosage adjustment when used concurrently.
Option D) None of the listed drugs pose a risk when taken with methylxanthines is incorrect because, as explained above, certain drugs can interact with methylxanthines, affecting their metabolism and efficacy.
Educationally, this question highlights the importance of understanding drug interactions, especially in patients with chronic conditions like asthma who may be on multiple medications. Nurses need to be aware of potential interactions to ensure safe and effective pharmacological management for their patients.